1326.2000 12.90 (0.98%)
NSE Jun 19, 2025 12:03 PM
Volume: 594.7K
 

Karvy
US business declines, margins outperform: DRL's revenues increased by 7% YoY to Rs 37.9 bn (lower than our estimates of Rs 38.9 bn) primarily due to de-growth in US business on account of higher pricing pressure due to incremental competition in some of the key products.
Dr. Reddy's Laborato.. has an average target of 1343.25 from 9 brokers.
More from Dr. Reddy's Laboratories Ltd.
Recommended